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Background 
Statin use in elderly individuals with life-limiting illness such as advanced dementia is 
controversial.  
Objective 
To describe factors associated with statin discontinuation and estimate impact of 
discontinuation on 28-day hospitalizations in nursing home (NH) residents with 
advanced dementia. 
Methods 
Retrospective cohort study of NH residents ≥ 65 years with recent progression to 
advanced dementia from 5 large U.S. states drawn from the 2007-2008 Minimum Data 
Set 2.0. We identified residents using statins. Clinical characteristics and 28-day 
hospitalization risk were compared for residents discontinuing and continuing statins. 
Multivariable Cox proportional hazard models identified factors associated with time to 
statin discontinuation and time to hospitalization. Sensitivity analysis using self-
controlled case series examined the role of confounding-by-indication on risk estimation 
from the cohort approach.  
Results  
Of 10,212 residents with decline to advanced dementia, 16.6% were prescribed statins 
(n=1,699).  Statin users had mean age of 83.1 yrs, 68.9% were female, and mean 
medication burden was 10.3 (SD 4.8, range 1-31). Over one-third (n=632) discontinued 
in follow-up.  Median time to discontinuation was 36 days after decline to advanced 
dementia (IQR [25%, 75%]: 12 days, 110 days). After adjustment, factors independently 
associated with increased hazard of discontinuation included residence in a NH in 
Florida relative to California, hospitalization in the 30 days prior to decline to advanced 
dementia, greater medication burden, and having cancer. The 28-day hospitalization 
risk was higher for residents discontinuing statins compared to continuing (adjusted 
hazard ratio = 1.78, CI 1.61,2.58). The SCCS estimate for 28-day hospitalization risk 
following statin discontinuation compared to a 28-day pre-discontinuation control period 
was lower than the cohort estimate (IRR= 0.79, CI 0.76, 0.83). 
Conclusion 
A significant proportion of nursing home residents with dementia who use statins when 
they progress to advanced stage disease discontinue use. Hospitalization outcomes 
following discontinuation differ depending on method of estimation.   
